BiOptic has won the 20th Pharmaceutical Technology Research & Development Award- Golden Award

The “20^th Pharmaceutical Technology Research and Development (PTRD) Award” is the only award which authorized by dual central agency including the Ministry of Health and Welfare and the Ministry of Economic Affairs in Taiwan. It has the reputation of Taiwan's Nobel Prize in pharmaceutical technology fields and there are 14 excellent candidates including BiOptic Inc. in the medical equipment group in 2021. On the 30^th of November, 2021, the greatest honored golden award was presented to BiOptic Inc.(Taiwan Emerging Stock Board, Stock Symbol: 6850), the only company that manufactured capillary electrophoresis related products in Asia. This Award is to reward the outstanding contributions to continuous innovative R&D, and to enhance the international competitiveness of Taiwan's biotechnology industry. 

BiOptic Inc. has won the award for its “Qsep series bio-fragment analyzer”. After going through several months of fierce competition and the review process, BiOptic Inc. finally stood out and won the golden award. "Qsep series bio-fragment analyzer" is independently developed by BiOptic Inc, with the patented optical modules. Since the first product commercialized in 2011, the product line has been extended and developed for different market needs, and the products are sold all over the world through the international distribution network. At present, there are more than 40 distributors around the world, and the products are sold to more than 50 countries.

BiOptic Inc. is committed to providing global customers with an "accurate, fast, and intuitive" genetic testing platform. Qsep series bio-fragment analyzers can be adapted to various fields and perfectly meet the needs of customers. We hope that genetic testing can be more popular and improving the overall health of human beings.

Original Report from Ministry of Health and Welfare, R.O.C.